nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—chronic obstructive pulmonary disease	0.466	1	CbGaD
Dicyclomine—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.141	0.374	CbGbCtD
Dicyclomine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.123	0.326	CbGbCtD
Dicyclomine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.113	0.3	CbGbCtD
Dicyclomine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.00262	CcSEcCtD
Dicyclomine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000354	0.00262	CcSEcCtD
Dicyclomine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.0026	CcSEcCtD
Dicyclomine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000352	0.0026	CcSEcCtD
Dicyclomine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00259	CcSEcCtD
Dicyclomine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00259	CcSEcCtD
Dicyclomine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00258	CcSEcCtD
Dicyclomine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00258	CcSEcCtD
Dicyclomine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00256	CcSEcCtD
Dicyclomine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00256	CcSEcCtD
Dicyclomine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000347	0.00256	CcSEcCtD
Dicyclomine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000341	0.00252	CcSEcCtD
Dicyclomine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00251	CcSEcCtD
Dicyclomine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000337	0.00249	CcSEcCtD
Dicyclomine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.00246	CcSEcCtD
Dicyclomine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00245	CcSEcCtD
Dicyclomine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00245	CcSEcCtD
Dicyclomine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00244	CcSEcCtD
Dicyclomine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00242	CcSEcCtD
Dicyclomine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00242	CcSEcCtD
Dicyclomine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00242	CcSEcCtD
Dicyclomine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000327	0.00241	CcSEcCtD
Dicyclomine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000326	0.00241	CcSEcCtD
Dicyclomine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.00241	CcSEcCtD
Dicyclomine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000324	0.0024	CcSEcCtD
Dicyclomine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00238	CcSEcCtD
Dicyclomine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00238	CcSEcCtD
Dicyclomine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00237	CcSEcCtD
Dicyclomine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00032	0.00236	CcSEcCtD
Dicyclomine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000318	0.00235	CcSEcCtD
Dicyclomine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000316	0.00233	CcSEcCtD
Dicyclomine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000316	0.00233	CcSEcCtD
Dicyclomine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000316	0.00233	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.00231	CcSEcCtD
Dicyclomine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00231	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.0023	CcSEcCtD
Dicyclomine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00229	CcSEcCtD
Dicyclomine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000309	0.00228	CcSEcCtD
Dicyclomine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000309	0.00228	CcSEcCtD
Dicyclomine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000308	0.00228	CcSEcCtD
Dicyclomine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.00228	CcSEcCtD
Dicyclomine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.00228	CcSEcCtD
Dicyclomine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.00225	CcSEcCtD
Dicyclomine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000304	0.00225	CcSEcCtD
Dicyclomine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00225	CcSEcCtD
Dicyclomine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000303	0.00224	CcSEcCtD
Dicyclomine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00223	CcSEcCtD
Dicyclomine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.00222	CcSEcCtD
Dicyclomine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000301	0.00222	CcSEcCtD
Dicyclomine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.0022	CcSEcCtD
Dicyclomine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000298	0.0022	CcSEcCtD
Dicyclomine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.0022	CcSEcCtD
Dicyclomine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00219	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000295	0.00218	CcSEcCtD
Dicyclomine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00215	CcSEcCtD
Dicyclomine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00215	CcSEcCtD
Dicyclomine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00215	CcSEcCtD
Dicyclomine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00215	CcSEcCtD
Dicyclomine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00215	CcSEcCtD
Dicyclomine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000287	0.00212	CcSEcCtD
Dicyclomine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00211	CcSEcCtD
Dicyclomine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00211	CcSEcCtD
Dicyclomine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000286	0.00211	CcSEcCtD
Dicyclomine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00211	CcSEcCtD
Dicyclomine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00211	CcSEcCtD
Dicyclomine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.0021	CcSEcCtD
Dicyclomine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000285	0.0021	CcSEcCtD
Dicyclomine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.0021	CcSEcCtD
Dicyclomine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.00209	CcSEcCtD
Dicyclomine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000282	0.00208	CcSEcCtD
Dicyclomine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00207	CcSEcCtD
Dicyclomine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00207	CcSEcCtD
Dicyclomine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.00206	CcSEcCtD
Dicyclomine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00203	CcSEcCtD
Dicyclomine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00203	CcSEcCtD
Dicyclomine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.002	CcSEcCtD
Dicyclomine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.002	CcSEcCtD
Dicyclomine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00199	CcSEcCtD
Dicyclomine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00027	0.00199	CcSEcCtD
Dicyclomine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00198	CcSEcCtD
Dicyclomine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000266	0.00197	CcSEcCtD
Dicyclomine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00195	CcSEcCtD
Dicyclomine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00195	CcSEcCtD
Dicyclomine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00194	CcSEcCtD
Dicyclomine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00192	CcSEcCtD
Dicyclomine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00192	CcSEcCtD
Dicyclomine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00191	CcSEcCtD
Dicyclomine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00191	CcSEcCtD
Dicyclomine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00191	CcSEcCtD
Dicyclomine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000257	0.0019	CcSEcCtD
Dicyclomine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.0019	CcSEcCtD
Dicyclomine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00189	CcSEcCtD
Dicyclomine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00189	CcSEcCtD
Dicyclomine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00187	CcSEcCtD
Dicyclomine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000253	0.00187	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00186	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00186	CcSEcCtD
Dicyclomine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00186	CcSEcCtD
Dicyclomine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00186	CcSEcCtD
Dicyclomine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00186	CcSEcCtD
Dicyclomine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000249	0.00184	CcSEcCtD
Dicyclomine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.00184	CcSEcCtD
Dicyclomine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.00184	CcSEcCtD
Dicyclomine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000249	0.00184	CcSEcCtD
Dicyclomine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00184	CcSEcCtD
Dicyclomine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00183	CcSEcCtD
Dicyclomine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00183	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00182	CcSEcCtD
Dicyclomine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00182	CcSEcCtD
Dicyclomine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00181	CcSEcCtD
Dicyclomine—CHRM2—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000245	0.0116	CbGpPWpGaD
Dicyclomine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00181	CcSEcCtD
Dicyclomine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000244	0.0018	CcSEcCtD
Dicyclomine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000244	0.0018	CcSEcCtD
Dicyclomine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00179	CcSEcCtD
Dicyclomine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00178	CcSEcCtD
Dicyclomine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000241	0.00178	CcSEcCtD
Dicyclomine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00177	CcSEcCtD
Dicyclomine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00177	CcSEcCtD
Dicyclomine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00024	0.00177	CcSEcCtD
Dicyclomine—CYP1A1—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.000239	0.0113	CbGpPWpGaD
Dicyclomine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00177	CcSEcCtD
Dicyclomine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000239	0.00176	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00176	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00176	CcSEcCtD
Dicyclomine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00176	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00175	CcSEcCtD
Dicyclomine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00175	CcSEcCtD
Dicyclomine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00174	CcSEcCtD
Dicyclomine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00174	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00172	CcSEcCtD
Dicyclomine—CYP1A1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000232	0.011	CbGpPWpGaD
Dicyclomine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00171	CcSEcCtD
Dicyclomine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00171	CcSEcCtD
Dicyclomine—CHRM1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000231	0.0109	CbGpPWpGaD
Dicyclomine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.0017	CcSEcCtD
Dicyclomine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000231	0.0017	CcSEcCtD
Dicyclomine—CHRM3—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.00023	0.0109	CbGpPWpGaD
Dicyclomine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00023	0.0017	CcSEcCtD
Dicyclomine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00023	0.0017	CcSEcCtD
Dicyclomine—CHRM2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000228	0.0108	CbGpPWpGaD
Dicyclomine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00168	CcSEcCtD
Dicyclomine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00168	CcSEcCtD
Dicyclomine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000228	0.00168	CcSEcCtD
Dicyclomine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00168	CcSEcCtD
Dicyclomine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00168	CcSEcCtD
Dicyclomine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000226	0.00167	CcSEcCtD
Dicyclomine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000226	0.00167	CcSEcCtD
Dicyclomine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00166	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00166	CcSEcCtD
Dicyclomine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00163	CcSEcCtD
Dicyclomine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00161	CcSEcCtD
Dicyclomine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00161	CcSEcCtD
Dicyclomine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.00159	CcSEcCtD
Dicyclomine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000215	0.00159	CcSEcCtD
Dicyclomine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000215	0.00158	CcSEcCtD
Dicyclomine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00155	CcSEcCtD
Dicyclomine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00154	CcSEcCtD
Dicyclomine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00154	CcSEcCtD
Dicyclomine—CHRM3—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000209	0.00987	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.00979	CbGpPWpGaD
Dicyclomine—CYP1A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.00979	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.00979	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000207	0.00978	CbGpPWpGaD
Dicyclomine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00152	CcSEcCtD
Dicyclomine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00152	CcSEcCtD
Dicyclomine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00152	CcSEcCtD
Dicyclomine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00151	CcSEcCtD
Dicyclomine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000203	0.0015	CcSEcCtD
Dicyclomine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.0015	CcSEcCtD
Dicyclomine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00149	CcSEcCtD
Dicyclomine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00146	CcSEcCtD
Dicyclomine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00144	CcSEcCtD
Dicyclomine—CHRM1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000194	0.00919	CbGpPWpGaD
Dicyclomine—CHRM3—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000194	0.00916	CbGpPWpGaD
Dicyclomine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00143	CcSEcCtD
Dicyclomine—CYP1A1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000193	0.00915	CbGpPWpGaD
Dicyclomine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00142	CcSEcCtD
Dicyclomine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00142	CcSEcCtD
Dicyclomine—CHRM2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000192	0.00907	CbGpPWpGaD
Dicyclomine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00139	CcSEcCtD
Dicyclomine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00137	CcSEcCtD
Dicyclomine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00137	CcSEcCtD
Dicyclomine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00137	CcSEcCtD
Dicyclomine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00136	CcSEcCtD
Dicyclomine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00136	CcSEcCtD
Dicyclomine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00136	CcSEcCtD
Dicyclomine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00136	CcSEcCtD
Dicyclomine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00135	CcSEcCtD
Dicyclomine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00135	CcSEcCtD
Dicyclomine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00135	CcSEcCtD
Dicyclomine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00134	CcSEcCtD
Dicyclomine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000182	0.00134	CcSEcCtD
Dicyclomine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00133	CcSEcCtD
Dicyclomine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00133	CcSEcCtD
Dicyclomine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00133	CcSEcCtD
Dicyclomine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00132	CcSEcCtD
Dicyclomine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00131	CcSEcCtD
Dicyclomine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00129	CcSEcCtD
Dicyclomine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00129	CcSEcCtD
Dicyclomine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00128	CcSEcCtD
Dicyclomine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00128	CcSEcCtD
Dicyclomine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00128	CcSEcCtD
Dicyclomine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00128	CcSEcCtD
Dicyclomine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00128	CcSEcCtD
Dicyclomine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00127	CcSEcCtD
Dicyclomine—CYP1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000171	0.00809	CbGpPWpGaD
Dicyclomine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00126	CcSEcCtD
Dicyclomine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00017	0.00125	CcSEcCtD
Dicyclomine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00791	CbGpPWpGaD
Dicyclomine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00123	CcSEcCtD
Dicyclomine—CYP1A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000165	0.00781	CbGpPWpGaD
Dicyclomine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00121	CcSEcCtD
Dicyclomine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.0012	CcSEcCtD
Dicyclomine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00119	CcSEcCtD
Dicyclomine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00117	CcSEcCtD
Dicyclomine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00117	CcSEcCtD
Dicyclomine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00115	CcSEcCtD
Dicyclomine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.00114	CcSEcCtD
Dicyclomine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00111	CcSEcCtD
Dicyclomine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00108	CcSEcCtD
Dicyclomine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.00105	CcSEcCtD
Dicyclomine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.00105	CcSEcCtD
Dicyclomine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00104	CcSEcCtD
Dicyclomine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00104	CcSEcCtD
Dicyclomine—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00641	CbGpPWpGaD
Dicyclomine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000997	CcSEcCtD
Dicyclomine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000978	CcSEcCtD
Dicyclomine—CHRM3—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.000131	0.00619	CbGpPWpGaD
Dicyclomine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000963	CcSEcCtD
Dicyclomine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000961	CcSEcCtD
Dicyclomine—CHRM2—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.00013	0.00613	CbGpPWpGaD
Dicyclomine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000954	CcSEcCtD
Dicyclomine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000949	CcSEcCtD
Dicyclomine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000936	CcSEcCtD
Dicyclomine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000931	CcSEcCtD
Dicyclomine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000926	CcSEcCtD
Dicyclomine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000912	CcSEcCtD
Dicyclomine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000896	CcSEcCtD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000119	0.00563	CbGpPWpGaD
Dicyclomine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000873	CcSEcCtD
Dicyclomine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000859	CcSEcCtD
Dicyclomine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000847	CcSEcCtD
Dicyclomine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000847	CcSEcCtD
Dicyclomine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000834	CcSEcCtD
Dicyclomine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000831	CcSEcCtD
Dicyclomine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000827	CcSEcCtD
Dicyclomine—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000112	0.00529	CbGpPWpGaD
Dicyclomine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000808	CcSEcCtD
Dicyclomine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000109	0.00517	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000107	0.00508	CbGpPWpGaD
Dicyclomine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000771	CcSEcCtD
Dicyclomine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000766	CcSEcCtD
Dicyclomine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000761	CcSEcCtD
Dicyclomine—CHRM3—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.000102	0.00484	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.000101	0.00479	CbGpPWpGaD
Dicyclomine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000746	CcSEcCtD
Dicyclomine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.98e-05	0.000736	CcSEcCtD
Dicyclomine—Rash—Prednisolone—chronic obstructive pulmonary disease	9.96e-05	0.000735	CcSEcCtD
Dicyclomine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.95e-05	0.000734	CcSEcCtD
Dicyclomine—Fatigue—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.00073	CcSEcCtD
Dicyclomine—Headache—Prednisolone—chronic obstructive pulmonary disease	9.89e-05	0.00073	CcSEcCtD
Dicyclomine—Constipation—Prednisone—chronic obstructive pulmonary disease	9.81e-05	0.000725	CcSEcCtD
Dicyclomine—CHRM2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	9.67e-05	0.00458	CbGpPWpGaD
Dicyclomine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.46e-05	0.000698	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	9.38e-05	0.000693	CcSEcCtD
Dicyclomine—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.38e-05	0.000693	CcSEcCtD
Dicyclomine—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.000673	CcSEcCtD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	9.09e-05	0.0043	CbGpPWpGaD
Dicyclomine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.07e-05	0.00067	CcSEcCtD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	9.06e-05	0.00429	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	8.98e-05	0.00425	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	8.88e-05	0.0042	CbGpPWpGaD
Dicyclomine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	8.85e-05	0.00419	CbGpPWpGaD
Dicyclomine—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	8.82e-05	0.00417	CbGpPWpGaD
Dicyclomine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	8.74e-05	0.00413	CbGpPWpGaD
Dicyclomine—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.67e-05	0.0041	CbGpPWpGaD
Dicyclomine—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.57e-05	0.00405	CbGpPWpGaD
Dicyclomine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000624	CcSEcCtD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	8.32e-05	0.00393	CbGpPWpGaD
Dicyclomine—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.23e-05	0.000608	CcSEcCtD
Dicyclomine—CHRM1—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	8.15e-05	0.00386	CbGpPWpGaD
Dicyclomine—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000599	CcSEcCtD
Dicyclomine—CHRM1—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	8.12e-05	0.00384	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	7.79e-05	0.00369	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	7.77e-05	0.00367	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	7.69e-05	0.00364	CbGpPWpGaD
Dicyclomine—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.00056	CcSEcCtD
Dicyclomine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	7.54e-05	0.00357	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	7.44e-05	0.00352	CbGpPWpGaD
Dicyclomine—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000539	CcSEcCtD
Dicyclomine—Rash—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000534	CcSEcCtD
Dicyclomine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.23e-05	0.000534	CcSEcCtD
Dicyclomine—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.2e-05	0.00341	CbGpPWpGaD
Dicyclomine—Headache—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000531	CcSEcCtD
Dicyclomine—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.1e-05	0.00336	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.04e-05	0.00333	CbGpPWpGaD
Dicyclomine—Nausea—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000503	CcSEcCtD
Dicyclomine—CHRM1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	6.6e-05	0.00312	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	6.58e-05	0.00311	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	6.57e-05	0.00311	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	6.46e-05	0.00306	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.34e-05	0.003	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	6.34e-05	0.003	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.09e-05	0.00288	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	6.03e-05	0.00285	CbGpPWpGaD
Dicyclomine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.03e-05	0.00285	CbGpPWpGaD
Dicyclomine—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.01e-05	0.00284	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	5.93e-05	0.00281	CbGpPWpGaD
Dicyclomine—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.92e-05	0.0028	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	5.91e-05	0.0028	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	5.9e-05	0.00279	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	5.88e-05	0.00278	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	5.86e-05	0.00277	CbGpPWpGaD
Dicyclomine—CHRM1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	5.77e-05	0.00273	CbGpPWpGaD
Dicyclomine—CHRM3—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	5.75e-05	0.00272	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	5.7e-05	0.0027	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	5.69e-05	0.00269	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	5.63e-05	0.00266	CbGpPWpGaD
Dicyclomine—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.52e-05	0.00261	CbGpPWpGaD
Dicyclomine—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.44e-05	0.00258	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APIP—chronic obstructive pulmonary disease	5.3e-05	0.00251	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	5.16e-05	0.00244	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	5.14e-05	0.00243	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	5.06e-05	0.0024	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.89e-05	0.00231	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.87e-05	0.0023	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.86e-05	0.0023	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.84e-05	0.00229	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.82e-05	0.00228	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.8e-05	0.00227	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	4.72e-05	0.00223	CbGpPWpGaD
Dicyclomine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.46e-05	0.00211	CbGpPWpGaD
Dicyclomine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.45e-05	0.0021	CbGpPWpGaD
Dicyclomine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.4e-05	0.00208	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.37e-05	0.00207	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.35e-05	0.00206	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.31e-05	0.00204	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	4.21e-05	0.00199	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.16e-05	0.00197	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.15e-05	0.00196	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.11e-05	0.00194	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.07e-05	0.00192	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	3.97e-05	0.00188	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.9e-05	0.00185	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.82e-05	0.00181	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.81e-05	0.0018	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.78e-05	0.00179	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.77e-05	0.00178	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.77e-05	0.00178	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.73e-05	0.00176	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.72e-05	0.00176	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.71e-05	0.00176	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.67e-05	0.00174	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.51e-05	0.00166	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	3.41e-05	0.00162	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.35e-05	0.00159	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.34e-05	0.00158	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.33e-05	0.00157	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.32e-05	0.00157	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.31e-05	0.00157	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.3e-05	0.00156	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.28e-05	0.00155	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.17e-05	0.0015	CbGpPWpGaD
Dicyclomine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.12e-05	0.00148	CbGpPWpGaD
Dicyclomine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.11e-05	0.00147	CbGpPWpGaD
Dicyclomine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.08e-05	0.00146	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.04e-05	0.00144	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.04e-05	0.00144	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.01e-05	0.00142	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3e-05	0.00142	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.94e-05	0.00139	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.94e-05	0.00139	CbGpPWpGaD
Dicyclomine—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.93e-05	0.00139	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.91e-05	0.00138	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.91e-05	0.00138	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.9e-05	0.00137	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.87e-05	0.00136	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.83e-05	0.00134	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.79e-05	0.00132	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.77e-05	0.00131	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	2.71e-05	0.00128	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.52e-05	0.00119	CbGpPWpGaD
Dicyclomine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.36e-05	0.00112	CbGpPWpGaD
Dicyclomine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.35e-05	0.00111	CbGpPWpGaD
Dicyclomine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.33e-05	0.0011	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.33e-05	0.0011	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.32e-05	0.0011	CbGpPWpGaD
Dicyclomine—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.28e-05	0.00108	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.23e-05	0.00106	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.22e-05	0.00105	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.2e-05	0.00104	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.1e-05	0.000995	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.1e-05	0.000992	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.08e-05	0.000982	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.06e-05	0.000977	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.91e-05	0.000904	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.9e-05	0.000901	CbGpPWpGaD
Dicyclomine—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.89e-05	0.000894	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.89e-05	0.000892	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.88e-05	0.000889	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.87e-05	0.000886	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.87e-05	0.000882	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.86e-05	0.000878	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	1.84e-05	0.000872	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.8e-05	0.000851	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.8e-05	0.00085	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.79e-05	0.000848	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.79e-05	0.000848	CbGpPWpGaD
Dicyclomine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.79e-05	0.000847	CbGpPWpGaD
Dicyclomine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.79e-05	0.000844	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.78e-05	0.00084	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.77e-05	0.000839	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.71e-05	0.000808	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.7e-05	0.000805	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.68e-05	0.000797	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	1.68e-05	0.000796	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.64e-05	0.000778	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.64e-05	0.000775	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.62e-05	0.000768	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.55e-05	0.000733	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.49e-05	0.000706	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.49e-05	0.000704	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.48e-05	0.000701	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.47e-05	0.000697	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.46e-05	0.000693	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000646	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.34e-05	0.000632	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.32e-05	0.000622	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.31e-05	0.00062	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.3e-05	0.000614	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.29e-05	0.000612	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.28e-05	0.000603	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.23e-05	0.000583	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.22e-05	0.000578	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.22e-05	0.000577	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.21e-05	0.000571	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.19e-05	0.000562	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.13e-05	0.000534	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.13e-05	0.000533	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.12e-05	0.000532	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.11e-05	0.000527	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	0.000486	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.02e-05	0.000481	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.01e-05	0.000479	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.01e-05	0.000479	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.01e-05	0.000477	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.01e-05	0.000476	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1e-05	0.000474	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.95e-06	0.000471	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.44e-06	0.000447	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.22e-06	0.000436	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.2e-06	0.000435	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.16e-06	0.000434	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.14e-06	0.000432	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.11e-06	0.000431	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.05e-06	0.000428	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.82e-06	0.000417	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.79e-06	0.000416	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.71e-06	0.000412	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.2e-06	0.000388	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.17e-06	0.000387	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.09e-06	0.000383	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	7.66e-06	0.000362	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	7.32e-06	0.000346	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.74e-06	0.000319	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.72e-06	0.000318	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.66e-06	0.000315	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.43e-06	0.000304	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.41e-06	0.000303	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.35e-06	0.000301	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.14e-06	0.000291	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.12e-06	0.00029	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	6.08e-06	0.000288	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.06e-06	0.000287	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.82e-06	0.000275	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.45e-06	0.000258	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.43e-06	0.000257	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.38e-06	0.000254	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.18e-06	0.000245	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.17e-06	0.000244	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.12e-06	0.000242	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.93e-06	0.000233	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.91e-06	0.000232	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.87e-06	0.00023	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.43e-06	0.000209	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.41e-06	0.000209	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.37e-06	0.000207	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.06e-06	0.000192	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.05e-06	0.000192	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.01e-06	0.00019	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.98e-06	0.000188	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.97e-06	0.000188	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.93e-06	0.000186	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.34e-06	0.000158	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.33e-06	0.000158	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.3e-06	0.000156	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.06e-06	0.000145	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.05e-06	0.000144	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.02e-06	0.000143	CbGpPWpGaD
